| 2018 | 2017 | % Change | |
| March Sales | 17,432 | 18,266 | -4.6 |
| Total Sales | 40,887 | 43,561 | -6.1 |
NASHVILLE, Tenn., April 03, 2018 -- INFINITI today reported sales of 17,432 vehicles in the U.S. during March, down 5%.
Deliveries of the all-new 2019 QX50, powered by the world’s first variable compression engine, began in March, contributing to the luxury crossover’s best March, with 1,913 total sold, up 11%.
The Q50 sports sedan increased 34% to 5,085 in March, up 12% for the year. Overall INFINITI sedans and coupes were up 2.6% in March.
The updated QX80 premium full-size SUV also had its best March, with an increase of 5%. The QX60 premium crossover had an all-time sales record of 5,115 delivered, up 34% in March and 39% for the year.
| Mar | Mar | Monthly | CYTD | CYTD | CYTD | ||||||
| 2018 | 2017 | % chg | 2018 | 2017 | % chg | ||||||
| INFINITI Total | 17,432 | 18,266 | -4.6 | 40,887 | 43,561 | -6.1 | |||||
| Q40 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Q50 | 5,085 | 3,800 | 33.8 | 11,701 | 10,450 | 12.0 | |||||
| Q60 | 1,136 | 1,829 | -37.9 | 2,603 | 3,371 | -22.8 | |||||
| Q70 | 655 | 1,072 | -38.9 | 1,491 | 1,962 | -24.0 | |||||
| QX30 | 1,227 | 2,960 | -58.5 | 2,815 | 6,532 | -56.9 | |||||
| QX50 | 1,913 | 1,724 | 11.0 | 4,084 | 4,318 | -5.4 | |||||
| QX60 | 5,115 | 3,821 | 33.9 | 12,024 | 8,668 | 38.7 | |||||
| QX70 | 221 | 1,077 | -79.5 | 570 | 2,905 | -80.4 | |||||
| QX80 | 2,080 | 1,983 | 4.9 | 5,599 | 5,355 | 4.6 | |||||
| Car | 6,876 | 6,701 | 2.6 | 15,795 | 15,783 | 0.1 | |||||
| CUV/SUV | 10,556 | 11,565 | -8.7 | 25,092 | 27,778 | -9.7 | |||||
About INFINITI
INFINITI Motor Company Ltd. is headquartered in Hong Kong with sales operations in over 50 countries. The INFINITI brand was launched in 1989. Its range of premium automobiles is currently built in manufacturing facilities in Japan, the United States, United Kingdom and China. INFINITI plans to also expand manufacturing into Mexico by 2017. INFINITI design studios are located in Atsugi-Shi near Yokohama, London, San Diego and Beijing.
INFINITI is in the middle of a major product offensive. The brand has been widely acclaimed for its daring design and innovative driver-assistance technologies. From the 2016 season, INFINITI is a technical partner of the Renault Sport Formula 1® team, contributing its expertise in hybrid performance.
More information about INFINITI and its industry-leading technologies can be found at www.infiniti.com/. You can also follow us on Facebook, Twitter, LinkedIn and see all our latest videos on YouTube.
Contact
Alexandra Amelang
Manager, INFINITI USA Communications
615-725-1455
[email protected]
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a028ac15-28cf-443f-b128-6fe459a54b4f


Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Anta Sports Expands Global Footprint With Strategic Puma Stake
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



